Assessment of the Clinical Profile of Dyspepsia with Predominantly Abdominal Bloating Symptoms in Type 2 Diabetes Mellitus Patients: A Cross-sectional Observational Study
Nidhi Bhutra, Ravi Kant, Itish Patnaik, Vandana K Dhingra
Citation Information :
Bhutra N, Kant R, Patnaik I, Dhingra VK. Assessment of the Clinical Profile of Dyspepsia with Predominantly Abdominal Bloating Symptoms in Type 2 Diabetes Mellitus Patients: A Cross-sectional Observational Study. Bengal Physician Journal 2024; 11 (3):120-124.
Aim and background: Diabetes mellitus virtually affects every organ in the body. Gastrointestinal effects include small intestinal bacterial overgrowth (SIBO), gastrointestinal reflux disease, gastroparesis, neuropathy, pancreatopathy, and non-alcoholic fatty liver disease. Our study aimed to assess and identify various causes of dyspepsia in type 2 diabetes mellitus (DM) patients.
Materials and methods: After screening the patients for inclusion and exclusion criteria, enrolled participants were subjected to a urea breath test (UBT), glucose hydrogen breath test (HBT), upper gastrointestinal endoscopy (UGIE), pancreatic fecal elastase (PEF), and gastric scintigraphy.
Results: The study revealed that 42.5% of patients had positive UBT for H. pylori gastritis, while 37.5% had organic causes of dyspepsia. Pancreatic exocrine insufficiency (PEI) was present in 37.5% of patients, and slow gastric emptying in 12.5% suggested gastroparesis. There was significant negative correlation between HbA1c and pancreatic fecal elastase levels. In 26.8% of patients, no cause of dyspepsia could be identified, 34.2% had dyspepsia secondary to a single etiology; and 26.8% of patients had two underlying etiologies of dyspepsia. In contrast, the remaining had multiple causes of dyspepsia.
Conclusion and clinical significance: The study identified multiple causes of dyspepsia in type 2 diabetic patients in India, with a large proportion having PEI. Further studies are needed to determine if pancreatic enzyme supplementation can alleviate dyspeptic symptoms. In conclusion, dyspepsia in diabetic patients can be attributed to multiple coexisting causes, necessitating etiology-directed management.
Kadaj-Lipka R, Rydzewska G. Exocrine pancreatic insufficiency and causes of abdominal symptoms in diabetes patients. Gastroenterol Rev/Przegląd Gastroenterol 2020;15(4):289–293. DOI: 10.5114/pg.2020.101556.
Meldgaard T, Keller J, Olesen AE, et al. Pathophysiology and management of diabetic gastroenteropathy. Therap Adv Gastroenterol 2019;12:1756284819852047. DOI: 10.1177/1756284819852047.
Osipenko MF, Zhuk EA, Medvedeva OV. Clinical characteristics of dyspepsia in patients with diabetes mellitus type 2. Ter Arkh 2013;85(2):43–47.
Corazza GR, Strocchi A, Gasbarrini G. Fasting breath hydrogen in celiac disease. Gastroenterology 1987;93(1):53–58. DOI: 10.1016/0016-5085(87)90313-1.
Kouitcheu Mabeku LB, Noundjeu Ngamga ML, et al. Helicobacter pylori infection, a risk factor for type 2 diabetes mellitus: A hospital-based cross-sectional study among dyspeptic 124 patients in Douala-Cameroon. Sci Rep 2020;10(1):1–11. DOI: 10.1038/s41598-020-69208-3.
Bener A, Ağan A, Al-human AAA, et al. Prevalence of Helicobacter pylori infection among type 2 diabetes mellitus. Adv Biomed Res 2020;9(1):27. DOI: 10.4103/abr.abr_248_19.
Quatrini M, Boarino V, Ghidoni A, et al. Helicobacter pylori prevalence in patients with diabetes and its relationship to dyspeptic symptoms. J Clin Gastroenterol 2001;32(3):215. DOI: 10.1097/00004836-200103000-00006.
Feng X, Li X-Q. The prevalence of small intestinal bacterial overgrowth in diabetes mellitus: A systematic review and meta-analysis. Aging (Albany NY) 2022;14(2):975–988. DOI: 10.18632/aging.203854.
Rana SV, Malik A, Bhadada SK, et al. Malabsorption, orocecal transit time and small intestinal bacterial overgrowth in type 2 diabetic patients: A connection. Indian J Clin Biochem 2017;32(1):84–89. DOI: 10.1007/s12291-016-0569-6.
Joshi SR, Chowdhury S, Dharmalingam M, et al. Prevalence of pancreatic exocrine insufficiency among patients with diabetes mellitus in India. J Assoc Physicians India 2023;71(7):11–12. DOI: 10.59556/japi.71.0316.
Hardt PD, Hauenschild A, Nalop J, et al. High prevalence of exocrine pancreatic insufficiency in diabetes mellitus. A multicenter study screening fecal elastase 1 concentrations in 1,021 diabetic patients. Pancreatology 2003;3(5):395–402. DOI: 10.1159/000073655.
Almogbel RA, Alhussan FA, Alnasser SA, et al. Prevalence and risk factors of gastroparesis-related symptoms among patients with type 2 diabetes. Int J Health Sci 2016;10(3):397–404. PMID: 27610063.
Choung RS, Locke RG, Schleck CD, et al. Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population. Am J Gastroenterol 2012;107(1):82–88. DOI: 10.1038/ajg.2011.310.
Huang J. Analysis of the relationship between Helicobacter pylori infection and diabetic gastroparesis. Chin Med J (Engl). 2017;130(22):2680–5. 29. 2680–2685. DOI: 10.4103/0366-6999.218012.
Reddymasu SC, McCallum RW. Small intestinal bacterial overgrowth in gastroparesis: Are there any predictors? J Clin Gastroenterol. 2010;44(1): e8–e13. 1163–1171. DOI: 10.14309/ajg.0000000000000200.
El Kurdi B, Babar S, El Iskandarani M, et al. Factors that affect the prevalence of small intestinal bacterial overgrowth in chronic pancreatitis: A systematic review, meta-analysis, and meta-regression. Clin Transl Gastroenterol. 2019;10(9):e00072. DOI: 10.14309/ctg.0000000000000072.